🚀 VC round data is live in beta, check it out!
Jinyu Bio-Technology Co. Valuation Multiples
Discover revenue and EBITDA valuation multiples for Jinyu Bio-Technology Co. and similar public comparables like Anhui Anke Biotechnology, Bavarian Nordic, Ultragenyx, Pfizer India and more.
Jinyu Bio-Technology Co. Overview
About Jinyu Bio-Technology Co.
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
Founded
1992
HQ
Employees
907
Website
Sectors
Financials (FY)
EV
$2B
Jinyu Bio-Technology Co. Financials
Jinyu Bio-Technology Co. reported last fiscal year revenue of $184M and EBITDA of $51M.
In the same fiscal year, Jinyu Bio-Technology Co. generated $99M in gross profit, $51M in EBITDA, and $16M in net income.
Revenue (LTM)
Jinyu Bio-Technology Co. P&L
In the most recent fiscal year, Jinyu Bio-Technology Co. reported revenue of $184M and EBITDA of $51M.
Jinyu Bio-Technology Co. expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $184M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $99M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 54% | XXX | XXX | XXX |
| EBITDA | — | XXX | $51M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 28% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 11% | XXX | XXX | XXX |
| Net Profit | — | XXX | $16M | XXX | XXX | XXX |
| Net Margin | — | XXX | 9% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Jinyu Bio-Technology Co. Stock Performance
Jinyu Bio-Technology Co. has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Jinyu Bio-Technology Co.'s stock price is $2.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.7% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJinyu Bio-Technology Co. Valuation Multiples
Jinyu Bio-Technology Co. trades at 12.2x EV/Revenue multiple, and 43.9x EV/EBITDA.
EV / Revenue (LTM)
Jinyu Bio-Technology Co. Financial Valuation Multiples
As of April 16, 2026, Jinyu Bio-Technology Co. has market cap of $2B and EV of $2B.
Equity research analysts estimate Jinyu Bio-Technology Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Jinyu Bio-Technology Co. has a P/E ratio of 152.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 12.2x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 43.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 106.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 22.6x | XXX | XXX | XXX |
| P/E | — | XXX | 152.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 76.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jinyu Bio-Technology Co. Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Jinyu Bio-Technology Co. Margins & Growth Rates
Jinyu Bio-Technology Co.'s revenue in the last fiscal year declined by (21%).
Jinyu Bio-Technology Co.'s revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Jinyu Bio-Technology Co. Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (21%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (31%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 42% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Jinyu Bio-Technology Co. Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Jinyu Bio-Technology Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| Anhui Anke Biotechnology | XXX | XXX | XXX | XXX | XXX | XXX |
| Bavarian Nordic | XXX | XXX | XXX | XXX | XXX | XXX |
| Ultragenyx | XXX | XXX | XXX | XXX | XXX | XXX |
| Pfizer India | XXX | XXX | XXX | XXX | XXX | XXX |
| Organon | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jinyu Bio-Technology Co. M&A Activity
Jinyu Bio-Technology Co. acquired XXX companies to date.
Last acquisition by Jinyu Bio-Technology Co. was on XXXXXXXX, XXXXX. Jinyu Bio-Technology Co. acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Jinyu Bio-Technology Co.
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJinyu Bio-Technology Co. Investment Activity
Jinyu Bio-Technology Co. invested in XXX companies to date.
Jinyu Bio-Technology Co. made its latest investment on XXXXXXXX, XXXXX. Jinyu Bio-Technology Co. invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Jinyu Bio-Technology Co.
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jinyu Bio-Technology Co.
| When was Jinyu Bio-Technology Co. founded? | Jinyu Bio-Technology Co. was founded in 1992. |
| Where is Jinyu Bio-Technology Co. headquartered? | Jinyu Bio-Technology Co. is headquartered in China. |
| How many employees does Jinyu Bio-Technology Co. have? | As of today, Jinyu Bio-Technology Co. has over 907 employees. |
| Is Jinyu Bio-Technology Co. publicly listed? | Yes, Jinyu Bio-Technology Co. is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Jinyu Bio-Technology Co.? | Jinyu Bio-Technology Co. trades under 600201 ticker. |
| When did Jinyu Bio-Technology Co. go public? | Jinyu Bio-Technology Co. went public in 1999. |
| Who are competitors of Jinyu Bio-Technology Co.? | Jinyu Bio-Technology Co. main competitors are Anhui Anke Biotechnology, Bavarian Nordic, Ultragenyx, Pfizer India. |
| What is the current market cap of Jinyu Bio-Technology Co.? | Jinyu Bio-Technology Co.'s current market cap is $2B. |
| What is the current revenue of Jinyu Bio-Technology Co.? | Jinyu Bio-Technology Co.'s last fiscal year revenue is $184M. |
| What is the current EV/Revenue multiple of Jinyu Bio-Technology Co.? | Current revenue multiple of Jinyu Bio-Technology Co. is 12.2x. |
| Is Jinyu Bio-Technology Co. profitable? | No, Jinyu Bio-Technology Co. is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.